Eric Chen
Eric Chen
Retina Consultants of Houston, Houston Methodist Hospital
Verified email at houstonretina.com - Homepage
TitleCited byYear
Use of intravitreal bevacizumab as a preoperative adjunct for tractional retinal detachment repair in severe proliferative diabetic retinopathy
E Chen, CH Park
Retina 26 (6), 699-700, 2006
2372006
25-Gauge transconjunctival sutureless vitrectomy
E Chen
Current opinion in ophthalmology 18 (3), 188-193, 2007
1362007
Spectral domain optical coherence tomography as an effective screening test for hydroxychloroquine retinopathy (the “flying saucer” sign)
E Chen, DM Brown, MS Benz, RH Fish, TP Wong, RY Kim, JC Major
Clinical ophthalmology (Auckland, NZ) 4, 1151, 2010
1042010
Endophthalmitis after intravitreal injection: the importance of viridans streptococci
E Chen, MY Lin, J Cox, DM Brown
Retina 31 (8), 1525-1533, 2011
812011
Hypotony after 25-gauge vitrectomy using oblique versus direct cannula insertions in fluid-filled eyes
J Hsu, E Chen, O Gupta, MS Fineman, SJ Garg, CD Regillo
Retina 28 (7), 937-940, 2008
752008
Super-dose Anti-VEGF (SAVE) Trial: 2.0 mg intravitreal ranibizumab for recalcitrant neovascular macular degeneration–primary end point
DM Brown, E Chen, A Mariani, JC Major Jr, SAVE Study Group
Ophthalmology 120 (2), 349-354, 2013
722013
Intravitreal bevacizumab for refractory pigment epithelial detachment with occult choroidal neovascularization in age-related macular degeneration
E Chen, RS Kaiser, JF Vander
Retina 27 (4), 445-450, 2007
652007
Acute visual acuity loss following intravitreal bevacizumab for diabetic macular edema
E Chen, J Hsu, CH Park
Ophthalmic Surgery, Lasers and Imaging Retina 40 (1), 68-70, 2009
492009
Postinjection endophthalmitis rates and characteristics following intravitreal bevacizumab, ranibizumab, and aflibercept
N Rayess, E Rahimy, P Storey, CP Shah, JD Wolfe, E Chen, FC DeCroos, ...
American journal of ophthalmology 165, 88-93, 2016
362016
Macular atrophy in neovascular age-related macular degeneration with monthly versus treat-and-extend ranibizumab: findings from the TREX-AMD trial
NS Abdelfattah, M Al-Sheikh, S Pitetta, A Mousa, SVR Sadda, CC Wykoff, ...
Ophthalmology 124 (2), 215-223, 2017
282017
Comparison of spectral-domain and time-domain optical coherence tomography in the detection of neovascular age-related macular degeneration activity
JC Major Jr, CC Wykoff, AF Mariani, E Chen, DE Croft, DM Brown
Retina 34 (1), 48-54, 2014
262014
SAVE (Super-dose anti-VEGF) trial: 2.0 mg ranibizumab for recalcitrant neovascular age-related macular degeneration: 1-year results
CC Wykoff, DM Brown, E Chen, JC Major, DE Croft, A Mariani, TP Wong
Ophthalmic Surgery, Lasers and Imaging Retina 44 (2), 121-126, 2013
262013
Insight into 144 patients with ocular vascular events during VEGF antagonist injections
AM Mansour, M Shahin, PK Kofoed, MB Parodi, M Shami, SG Schwartz
Clinical ophthalmology (Auckland, NZ) 6, 343, 2012
242012
Incidence and clinical features of post-injection endophthalmitis according to diagnosis
N Rayess, E Rahimy, CP Shah, JD Wolfe, E Chen, FC DeCroos, P Storey, ...
British Journal of Ophthalmology 100 (8), 1058-1061, 2016
212016
ENDOPHTHALMITIS AFTER INTRAVITREAL INJECTION
AL Li, CC Wykoff, R Wang, E Chen, MS Benz, RH Fish, TP Wong, ...
Retina 36 (7), 1349-1356, 2016
202016
Use of nepafenac (Nevanac«) in combination with intravitreal anti-VEGF agents in the treatment of recalcitrant exudative macular degeneration requiring monthly injections
E Chen, MS Benz, RH Fish, DM Brown, TP Wong, RY Kim, JC Major
Clinical ophthalmology (Auckland, NZ) 4, 1249, 2010
182010
Lucentis« using Visudyne« study: determining the threshold-dose fluence of verteporfin photodynamic therapy combined with intravitreal ranibizumab for exudative maculará…
E Chen, DM Brown, TP Wong, MS Benz, E Kegley, J Cox, RH Fish, ...
Clinical ophthalmology (Auckland, NZ) 4, 1073, 2010
182010
Streptococcus mitis endophthalmitis presenting as frosted branch angiitis after intravitreal pegaptanib sodium injection
E Chen, AC Ho, SJ Garg, GC Brown, RS Kaiser
Ophthalmic Surgery, Lasers and Imaging Retina 40 (2), 192-194, 2009
172009
Factors predicting visual acuity outcome in intermediate, posterior, and panuveitis: the Multicenter Uveitis Steroid Treatment (MUST) trial
JH Kempen, ML Van Natta, MM Altaweel, JP Dunn, DA Jabs, SL Lightman, ...
American journal of ophthalmology 160 (6), 1133-1141. e9, 2015
152015
Dissociations of the fluocinolone acetonide implant: the Multicenter Uveitis Steroid Treatment (MUST) trial and follow-up study
JT Holbrook, EA Sugar, AE Burke, AT Vitale, JE Thorne, JL Davis, ...
American journal of ophthalmology 164, 29-36, 2016
132016
The system can't perform the operation now. Try again later.
Articles 1–20